Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 3 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 12188005

    NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  2. US 12180484

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  3. US 12180296

    Cross species single domain antibodies targeting mesothelin for treating solid tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  4. US 12178907

    Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  5. US 12171818

    Methods of isolating T cells having antigenic specificity for a cancer-specific mutation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  6. US 12172038

    Anti-coronavirus antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Svcs. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  7. US 12168008

    Oxabicycloheptanes for modulation of immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  8. US 12168675

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  9. US 12168802

    Methods of diagnosing and treating CD55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (CHAPLE), a newly identified orphan disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  10. US 12161733

    Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  11. US 12162910

    Recombinant gp120 protein with V1-loop deletion

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  12. US 12162861

    Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  13. US 12157762

    Tethered interleukin-15 and interleukin-21

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 3, 2024 · Expires Nov 28, 2044

    granted
  14. US 12145968

    Recombinant HIV-1 envelope proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  15. US 12145922

    Selective D3 dopamine receptor agonists and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  16. US 12138294

    Transgenic corn with antifungal peptide AGM182 (DN:0113.18)

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  17. US 12122843

    High affinity monoclonal antibodies targeting glypican-1 and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  18. US 12102671

    Method of vaccination with an attenuated RSV vaccine formulation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  19. US 12097196

    Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  20. US 12084489

    Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  21. US 12083246

    Composite gels and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  22. US 12077572

    Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  23. US 12071636

    Pasteurella multocida strains and vaccines having hyaC and nanP deletions

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  24. US 12071632

    Chimeric vectors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted